Join to view full profile
160 East 53rd StreetNew York, NY 10022
Dr. Rosenbaum is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2014 - 2017
Albert Einstein College of MedicineClass of 2014
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2016 - 2027
NC State Medical License 2021 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 2020 Sep 29
- A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma Start of enrollment: 2023 May 23
- A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy Start of enrollment: 2023 Oct 27
Publications & Presentations
PubMed
- Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.Adel Shahnam, Kristen DiConza, Simran Jasnani, Rhoena Desir-Camille, Evan Rosenbaum
Cancer Medicine. 2026-06-01 - Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, Evan Seffar, Mark A Dickson
Journal for Immunotherapy of Cancer. 2026-05-04 - 1 citationsAssociation of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, Martina Bradic, Jasme Lee
Clinical Cancer Research. 2026-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
